Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-09-16
1993-04-20
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514278, 544230, 546 17, A61K 31495, C07D47100, C07D40112
Patent
active
052043495
ABSTRACT:
Compounds of the formula: ##STR1## where R.sup.1 is hydrogen or hydroxy and R.sup.2 is a substituted amino group, a substituted heterocyclic ring or a substituted alkyl. These compounds are oxytocin and vasopressin antagonists useful in the treatment of preterm labor, dysmenorrhea and for the stoppage of labor preparatory to cesarean delivery, timing of parturition, uterine hyperactivity, endometriosis, hypertension, congestive heart failure, hyponatremia and cognitive disorders. Also disclosed are pharmaceutical compositions containing these compounds, methods of their use and methods of their preparation.
REFERENCES:
patent: 3301857 (1967-01-01), Berger et al.
patent: 3654287 (1972-04-01), Dykstra et al.
patent: 3666764 (1972-05-01), Campbell et al.
patent: 4379933 (1983-04-01), Ong et al.
J. Parm. Sci (1982) 71, 3 pp. 291-294, by Crooks, et al.
J. Org. Chem. (1971) 36, 5, pp. 650-654, by Matier, et al.
J. Org. Chem. (1976) 41, 15, pp. 2528-2633, by Parkam, et al.
J. Chromatography (1977) 136, pp. 401-407, by Bryce, et al.
Bock Mark G.
Evans Ben E.
Freidinger Roger M.
Gilbert Kevin
Hobbs Doug W.
Caruso Charles M.
Grassler Frank P.
Ivy C. Warren
Merck & Co. , Inc.
Trinh Ba K.
LandOfFree
Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Amide-substituted derivatives of spiroindanylcamphorsulfonyl oxy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1526294